| Literature DB >> 33772908 |
Jan Frank1, Klaus Kisters2, Ovidiu Alin Stirban3, Rima Obeid4, Stefan Lorkowski5,6, Maria Wallert5,6, Sarah Egert7, Maren C Podszun1, Gunter P Eckert8, Jacqueline A Pettersen9,10, Sascha Venturelli1, Hans-Georg Classen1, Jana Golombek11.
Abstract
The present demographic changes toward an aging society caused a rise in the number of senior citizens and the incidence and burden of age-related diseases (such as cardiovascular diseases [CVD], cancer, nonalcoholic fatty liver disease [NAFLD], diabetes mellitus, and dementia), of which nearly half is attributable to the population ≥60 years of age. Deficiencies in individual nutrients have been associated with increased risks for age-related diseases and high intakes and/or blood concentrations with risk reduction. Nutrition in general and the dietary intake of essential and nonessential biofactors is a major determinant of human health, the risk to develop age-related diseases, and ultimately of mortality in the older population. These biofactors can be a cost-effective strategy to prevent or, in some cases, even treat age-related diseases. Examples reviewed herein include omega-3 fatty acids and dietary fiber for the prevention of CVD, α-tocopherol (vitamin E) for the treatment of biopsy-proven nonalcoholic steatohepatitis, vitamin D for the prevention of neurodegenerative diseases, thiamine and α-lipoic acid for the treatment of diabetic neuropathy, and the role of folate in cancer epigenetics. This list of potentially helpful biofactors in the prevention and treatment of age-related diseases, however, is not exhaustive and many more examples exist. Furthermore, since there is currently no generally accepted definition of the term biofactors, we here propose a definition that, when adopted by scientists, will enable a harmonization and consistent use of the term in the scientific literature.Entities:
Keywords: biofactor definition; cancer epigenetics; cardiovascular diseases; diabetes mellitus; micronutrients; neurodegenerative diseases; nonalcoholic fatty liver disease
Mesh:
Substances:
Year: 2021 PMID: 33772908 DOI: 10.1002/biof.1728
Source DB: PubMed Journal: Biofactors ISSN: 0951-6433 Impact factor: 6.113